These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2342056)

  • 21. Total synthesis and revision of stereochemistry of the marine metabolite trunkamide A.
    Wipf P; Uto Y
    J Org Chem; 2000 Feb; 65(4):1037-49. PubMed ID: 10814052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic Hexapeptide Dimers, Antatollamides A and B, from the Ascidian Didemnum molle. A Tryptophan-Derived Auxiliary for l- and d-Amino Acid Assignments.
    Salib MN; Molinski TF
    J Org Chem; 2017 Oct; 82(19):10181-10187. PubMed ID: 28846849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
    Liang B; Richard DJ; Portonovo PS; Joullié MM
    J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate.
    Rinehart KL; Gloer JB; Hughes RG; Renis HE; McGovren JP; Swynenberg EB; Stringfellow DA; Kuentzel SL; Li LH
    Science; 1981 May; 212(4497):933-5. PubMed ID: 7233187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Potassium-Binding Hydrolysis Product of Ascidiacyclamide: A Cyclic Octapeptide Isolated from the Ascidian Lissoclinum patella.
    van Den Brenk AL; Fairlie DP; Gahan LR; Hanson GR; Hambley TW
    Inorg Chem; 1996 Feb; 35(5):1095-1100. PubMed ID: 11666295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure--activity relationships of the didemnins.
    Sakai R; Rinehart KL; Kishore V; Kundu B; Faircloth G; Gloer JB; Carney JR; Namikoshi M; Sun F; Hughes RG; García Grávalos D; de Quesada TG; Wilson GR; Heid RM
    J Med Chem; 1996 Jul; 39(14):2819-34. PubMed ID: 8709112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bistramides A, B, C, D, and K: a new class of bioactive cyclic polyethers from Lissoclinum bistratum.
    Biard JF; Roussakis C; Kornprobst JM; Gouiffes-Barbin D; Verbist JF; Cotelle P; Foster MP; Ireland CM; Debitus C
    J Nat Prod; 1994 Oct; 57(10):1336-45. PubMed ID: 7807120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of C11 cyclopentenones from two didemnid species, Lissoclinum sp. and Diplosoma sp.
    Ogi T; Margiastuti P; Teruya T; Taira J; Suenaga K; Ueda K
    Mar Drugs; 2009 Dec; 7(4):816-32. PubMed ID: 20098612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ; Corbett TH
    J Am Chem Soc; 2001 Jun; 123(23):5418-23. PubMed ID: 11389621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marine metabolites: metal binding and metal complexes of azole-based cyclic peptides of marine origin.
    Bertram A; Pattenden G
    Nat Prod Rep; 2007 Feb; 24(1):18-30. PubMed ID: 17268606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides.
    Wollinsky B; Ludwig L; Hamacher A; Yu X; Kassack MU; Li SM
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3866-9. PubMed ID: 22617493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and structure determination of nostocyclopeptides A1 and A2 from the terrestrial cyanobacterium Nostoc sp. ATCC53789.
    Golakoti T; Yoshida WY; Chaganty S; Moore RE
    J Nat Prod; 2001 Jan; 64(1):54-9. PubMed ID: 11170666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational properties of ascydiacyclamide analogues with cyclic α-amino acids instead of oxazoline residues.
    Asano A; Numata S; Yamada T; Minoura K; Doi M
    Bioorg Med Chem; 2017 Dec; 25(24):6554-6562. PubMed ID: 29097029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic peptide marine metabolites and CuII.
    Comba P; Dovalil N; Gahan LR; Hanson GR; Westphal M
    Dalton Trans; 2014 Feb; 43(5):1935-56. PubMed ID: 24202205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution forms of antitumor cyclic pentapeptides with 3,4-dichlorinated proline residues, astins A and C, from Aster tataricus.
    Morita H; Nagashima S; Takeya K; Itokawa H
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1395-7. PubMed ID: 7553986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new cyclic dipeptide from cultures of Coprinus plicatilis.
    Zhao JY; Ding JH; Li ZH; Feng T; Zhang HB; Liu JK
    Nat Prod Res; 2018 Apr; 32(8):972-976. PubMed ID: 28862058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scleritodermin A, a cytotoxic cyclic peptide from the lithistid sponge Scleritoderma nodosum.
    Schmidt EW; Raventos-Suarez C; Bifano M; Menendez AT; Fairchild CR; Faulkner DJ
    J Nat Prod; 2004 Mar; 67(3):475-8. PubMed ID: 15043437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella.
    Schmidt EW; Nelson JT; Rasko DA; Sudek S; Eisen JA; Haygood MG; Ravel J
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7315-20. PubMed ID: 15883371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stylissamide X, a new proline-rich cyclic octapeptide as an inhibitor of cell migration, from an Indonesian marine sponge of Stylissa sp.
    Arai M; Yamano Y; Fujita M; Setiawan A; Kobayashi M
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1818-21. PubMed ID: 22260773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational transformation of ascidiacyclamide analogues induced by incorporating enantiomers of phenylalanine, 1-naphthylalanine or 2-naphthylalanine.
    Asano A; Minoura K; Yamada T; Doi M
    J Pept Sci; 2016 Mar; 22(3):156-65. PubMed ID: 26856689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.